Bio Protocol
Last updated
Last updated
Bio Protocol is designed to make biotechnology more open, efficient and market-driven, from early-stage funding and liquidity, to milestone-based incentives and agentic automation. Users can create a new biotech project (BioDAO) and get it bootstrapped by the community, or directly fund and support promising biotech projects at their earliest stages, democratizing an area once limited to Big Pharma and pharma VCs.
Curation, creation and acceleration of new BioDAOs.
Perpetual funding and liquidity for BioDAOs and biotech assets.
Standardization of BioDAO frameworks, tokenomics and data/product suites.
Generation and commercialization of scientific IP and data.
To achieve these goals, the Bio Protocol enables 5 core operations:
Curation
Funding
Liquidity
Incentives
Agentic Automation
BIO token holders participate in curating which new BioDAOs join the ecosystem, enabling a bottom-up approach to funding and developing science.
BioDAOs that are selected by the community can then be funded, added to the treasury and ultimately supported by the Bio Protocol.
As the Bio Protocol relies on high-quality BioDAOs, curation requires locked BIO tokens to participate, ensuring that those participating are long-term aligned with the network.
If a BioDAO applicant is accepted into the BIO Network, all BIO holders who committed their tokens to the BioDAO in the Curation phase qualify to receive discounted BioDAO tokens.
Through BIO, users are thus able to support groundbreaking science from day one, on equal to or better terms than VCs or other institutions.
For BioDAOs, this creates an opportunity to align a pre-established, high-value scientific community (often made up researchers or patients directly affected by the BioDAO's scientific mission) to become active stakeholders and participants in R&D, e.g., through decentralized trials and research.
BioDAOs should focus on science, not managing liquidity. Bio Protocol alleviates this issue by managing BioDAO secondary market liquidity positions.
The protocol supports onchain liquidity using the BIO token and other token holdings in the Bio Protocol treasury.
The BIO token can be paired in liquidity pools with BioDAO tokens (e.g., VITA/BIO, HAIR/BIO), as well as with base assets (e.g., BIO/ETH) to facilitate low-cost conversions, accruing fees for the BioDAO and the protocol.
To ensure accountability, Bio enables milestone-based “bio/acc” incentives in the form of BIO tokens.
Projects can unlock bio/acc rewards by hitting critical R&D milestones, such as completing lab experiments, trials or earning product revenue.
This approach aligns everyone’s incentives toward real-world scientific outcomes, while creating standardization in success metrics across the network of BioDAOs.
BioAgents are AI-driven scientific researchers that automate tasks for BioDAOs such as data analysis, hypothesis generation, experiment design and IP claims.
BioDAOs leverage these “autonomous lab assistants” to speed up and reduce the cost of scientific development, while reading and writing to a decentralized knowledge graph integrated across BioDAOs.
BioAgents also open potential revenue streams, since external organizations can pay fees to access these AI services, creating a self-sustaining feedback loop for the ecosystem.
Rapid Research Funding – BioDAOs can select from a range of bonding curve and auction-based funding mechanisms, optimizing transparency, automation, and community-driven capital allocation.
Automated Liquidity – BIO token pledges enable onchain liquidity provisioning, ensuring sustainable market depth and fee generation for BioDAOs.
Agentic Science – Integrated BioAgents automate core scientific tasks, including data analysis, hypothesis testing, and experimental design and submission to labs, while CoreAgents streamline BioDAO governance and IP management.
Early Access – Pledged BIO secures pre-sale allocations in vetted BioDAOs, offering strategic entry at early-stage valuations.
Community Vetting – Capital deployment is conditional on collective approval, ensuring funds are only allocated to BioDAOs with sufficient community support.
Instant Liquidity – A portion of successfully raised funds is automatically injected into onchain liquidity pools, facilitating immediate, low-slippage trading.
Holders lock or stake BIO tokens to perform core functions on the network, like vetting new BioDAOs or running BioAgents. Protocol fees get recycled back into the ecosystem via liquidity or token burns to fuel growth, while the Bio Protocol Treasury can earn value in the following ways:
6.9% stake in each BioDAO launched via the Launchpad
Launchpad fees from trading, etc.
Percentage stake of IP-Tokens launched via the protocol
Protocol-owned liquidity
Fees from BioAgents
The BIO token can be used for the following purposes:
Curating BioDAOs to join the Bio Network
Facilitating onchain liquidity for BioDAOs
Meta-governance in BioDAOs
Running BioAgents
Discounts on BioDAO health products/services
Voting on treasury allocation and protocol updates
